Filing Details
- Accession Number:
- 0001179022-19-000035
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-03 17:31:51
- Reporting Period:
- 2019-05-31
- Accepted Time:
- 2019-06-03 17:31:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1133416 | Galectin Therapeutics Inc | GALT | Pharmaceutical Preparations (2834) | 043562325 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1522478 | D Kevin Freeman | C/O Galectin Therapeutics, Inc. 4960 Peachtree Industrial Blvd., Ste 240 Norcross GA 30071 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-31 | 7,710 | $4.28 | 9,710 | No | 4 | P | Indirect | By a limited liability company wholly-owned by Freeman Global Holdings, LLC |
| Common Stock | Acquisiton | 2019-05-31 | 1,426 | $4.28 | 23,469 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By a limited liability company wholly-owned by Freeman Global Holdings, LLC |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Purchase Warrant (right to buy) | Acquisiton | 2019-05-31 | 4,753 | $0.00 | 356 | $7.00 |
| Common Stock | Common Stock Purchase Warrant (right to buy) | Acquisiton | 2019-05-31 | 25,700 | $0.00 | 1,928 | $7.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,753 | 2019-11-30 | 2026-05-31 | No | 4 | P | Direct |
| 25,700 | 2019-11-30 | 2026-05-31 | No | 4 | P | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 16,000 | Indirect | IRA |
Footnotes
- Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- Each warrant is exerciseable for 0.075 shares of Common Stock of the Company.
Billionaire Hedge Funds
